What is Enzyme (MLN)?

Deep Dive

1. Purpose & Value Proposition

Enzyme aims to decentralize traditional asset management by moving it on-chain. It solves the problem of opaque, inefficient, and inaccessible fund management by providing a transparent, programmable, and permissionless infrastructure. This allows everyone from individual investors to large institutions and DAOs to create and manage customized investment vehicles, often called "vaults," with the same tools and security.

2. Ecosystem Fundamentals & Core Functionality

The protocol's core offering is its Vault-as-a-Service model. Users can deploy vaults as smart contracts to hold assets and execute strategies. These strategies can interact with various DeFi protocols for lending, trading, or providing liquidity. A key product is Enzyme Myso, an on-chain options protocol for creating structured yield products. The system is designed for cross-chain compatibility, allowing strategies to span different networks while being managed from a single dashboard.

3. Tokenomics & Governance

The MLN token operates on a mint-and-burn model to align incentives. Users pay a continuous fee (0.25% of vault assets per year) in MLN for accessing the network; these tokens are then burned, creating a deflationary pressure tied to platform usage. Separately, up to 300,600 new MLN are minted annually to fund protocol development and grants, as decided by the Enzyme Council DAO. Token holders can stake MLN to participate in governance votes on upgrades and fund allocations (Tokenomics | Enzyme Documentation).

Conclusion

Fundamentally, Enzyme is the foundational plumbing for a new era of transparent, on-chain investment products, powered by a token designed to capture value from its usage. As tokenized finance evolves, will its infrastructure-first approach become the standard for building complex financial strategies?